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INTRODUCTION
The decisions we make now will determine 
the course of the next 30 years and beyond: 
Emissions must fall by half by 2030 and reach 
net- zero emissions no later than 2050 to 
reach the 1.5C goal…If we fail to meet these 
goals, the disruption to economies, societies 
and people caused by COVID-19 will pale in 
comparison to what the climate crisis holds 
in store. (António Guterres, United Nations 
Secretary- General)1
The historical trajectories of three crises 
have converged in the 2020s: the COVID-19 
pandemic, rising inequality and the climate 
crisis. The political, social and institutional 
arrangements that have collectively constituted 
'global health,' and the potential obstacles and 
possibilities of the COVID-19 pandemic reveal 
the intersecting challenges of rising inequality 
and climate crisis. Emerging transformations in 
global health, accelerated by the sea changes 
of the 2020s, are characterised by attempts to 
expand notions of health and social justice 
encompassing planetary, racial, reproductive 
and digital justice. In this article, we discuss 
their intersection and suggest that a new set of 
organising ideals, institutions and norms will 
need to emerge from their conjunction if a just 
and liveable world is to remain a possibility for 
humans and their cohabitants.
THE END OF GLOBAL HEALTH?
'Global health' has been a contested project 
since its emergence as a framework and field 
of practice over 20 years ago.2 3 Variously 
conceived of as either ‘the health of popu-
lations in a global context’ or the particular 
assemblages of institutions, practices, tech-
nologies and norms that produce a field of 
concern called ‘global health,’ it has remained 
an unstable object of analysis.4 Critical global 
health scholarship, in particular, has attended 
closely to the configurations of knowledge 
and power that have defined global health as 
a political enterprise, scrutinising the forms of 
evidence, efficacy and accountability that are at 
work in its programmes and tracing the uneven 
delivery of its promises.4–8
The shift from international health to global 
health in the 1990s indexed changing geopo-
litical arrangements. It embodied a growing 
understanding that health transcends national 
boundaries and actors, and that chronic ineq-
uities were rooted in transnational determi-
nants (war, climate, neoliberalism) that only 
large- scale holistic perspectives could address. 
One criticism has been that instead of levelling 
the playing field, global health has reinscribed 
colonial power differentials, as discourses, tech-
nologies and priorities tend to be set by agen-
cies located in high- income countries (HICs) 
for export to the rest of the world.9 The ‘global’ 
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in global health has in practice referred to the reach of a 
small set of non- state actors—non- governmental organi-
sations, pharmaceutical companies, philanthropies and 
universities—capable of defining new health agendas for 
the planet.
The peculiar epistemology of global health emerged in 
the post- Cold War period from the widely shared belief 
that the transnational nature of contemporary threats to 
health—the propagation of infections through air travel, 
or the rise of chronic diseases associated with trade liber-
alisation and multinational corporations—could not be 
addressed through the old international health system, built 
around nation- states, but required new global solutions 
able to work across political and geographical borders.10–14 
These global solutions included novel funding mecha-
nisms like the Global Fund to Fight AIDS, Tuberculosis 
and Malaria, supranational regulatory arrangements like 
the WHO’s Framework Convention on Tobacco Control 
and infrastructures allowing medical commodities to travel 
more efficiently across borders.3 Influenced by the then 
dominant neoliberal view of the state, efforts to improve 
health focused on the role of non- state actors, such as civil 
society groups, private–public partnerships and philanthro-
pies. This was also an era characterised by a preference for 
portable micro- technologies—such as bed nets or point- of- 
care diagnostics—and pharmaceutical commodities over 
investments in national health infrastructures or efforts 
to transform political and economic systems.5 15–18 The 
successes associated with these newly global arrangements 
have nevertheless been significant, from malaria control 
(global rates fell by 60% between 2000 and 2015, although 
progress since has stalled) to the eradication of polio in 
Africa in 2020.
Yet the utility of ‘global health’ as a framework has come 
under increasing strain over the last decade, under the 
weight of shifting geopolitical interests, worsening inequal-
ities and the intensifying urgency of the climate crisis. Well 
before the COVID-19 crisis, the response to the HIV, Ebola 
or Zika epidemics showed that ‘therapeutic geographies’ 
continued to be profoundly shaped by histories of race, 
colonial legacies and postcolonial geopolitics.19–21 Long- 
standing discontent over the exclusion of expertise from 
the global South, the growing bifurcation between those 
providing and those receiving global health assistance, and 
the racialised nature of access to care in the global North 
have also come into sharper focus.22–25 In the meantime, 
new geopolitical cleavages, growing protectionism, the 
sidelining of the climate emergency, and the dissemination 
of powerful but unevenly impactful digital technologies are 
changing the meaning of ‘global’ and ‘health’ in rapid and 
at times unpredictable ways.
The COVID-19 response has thus far been charac-
terised by a reinforcement of some aspects of the global 
health episteme, such as the focus on biomedical solu-
tions, philanthropic models of pharmaceutical delivery, 
and measurable and cost- effective interventions. As histo-
rian Thomas Laqueur26 remarks, many people have expe-
rienced the COVID-19 pandemic through models and 
numbers developed and disseminated by epidemiologists, 
computer scientists, modellers and mathematicians. These 
are the numbers and models that governments across the 
world use to govern and control the epidemic, building on 
recent developments in data science, surveillance technol-
ogies and artificial intelligence.27 The potential for digital 
technologies to revolutionise public health has also come 
into sharp focus, with many governments investing in mass 
digital health surveillance and artificial intelligence solu-
tions despite the dramatic differences in individual access 
to digital services and measures for data protection.
Conversely, other aspects of global health are being chal-
lenged.28 National rather than global solutions have been 
at the forefront of the response. This is most obvious in 
relation to quarantine measures and lockdowns, with 
nation- states closing their borders, freezing their econo-
mies and limiting their citizens’ freedoms in previously 
unimaginable ways.29 It can also be seen in countries’ 
efforts to strengthen and expand their healthcare systems 
and capacities, redefining medical research infrastructures 
as matters of national security. The virtues of off- shoring 
industrial production have been put into question, as some 
countries seek to renationalise the production of masks, 
hand- sanitisers, ventilators and vaccines.30 ‘Vaccine nation-
alism’ remains a present threat to the ability to expand 
access across the world.31
Furthermore, trust in science and reason, foundational 
to global health and its formal commitment to ‘evidence- 
based’ interventions, has become precarious and contested. 
In liberal democracies, questions about the provenance 
and validity of scientific data have dominated debates over 
national lockdowns, and there has been significant back-
lash against individual experts or expert advisory bodies 
associated with the imposition of emergency measures. 
For example, Bill Gates, a key figure of global health, has 
become the target of conspiracy theories about the role of 
COVID-19 as the instrument of a new ‘world order’.32 33 In 
the wake of the proliferation of conspiracy theories about 
COVID-19 and their potential impact on vaccination and 
containment strategies, ‘infodemiology’ has emerged as 
a community of practice and research premised on the 
apparent infectiousness of information in the age of global-
ised social media. As a new chapter in health communi-
cation, infodemiology indexes a longer history of the 
mystification of global health governance for the lay public, 
including obscure patent laws, questionable metrics and 
opaque structures of accountability. Such tensions mani-
fest in the material sites of basic health systems; drugs and 
diagnostics (access, certification, regulation, infrastructure, 
distribution); data management, analytics and surveillance 
mechanisms; and the competing knowledge and expertise 
that inform global health governance. New tensions have 
also arisen between social justice as a core value for many 
global health workers who have been forced to ration scarce 
resources and a renewed call for solidarity to respond to 
the pandemic, racism and the climate crisis.34 These values 
will come under even greater pressure as questions about 
the equity of vaccine distribution accelerate.
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The rise and fall of ‘global health’ as a dominant set of 
policies and arrangements also tracks the rise (and arguably 
the failure) of planetary concerns with climate, biodiversity 
and sustainability. Global health has not (yet) departed 
from the anthropocentrism that lies at the root of these 
interlinked planetary crises ranging from: global heating 
and extreme weather to land use change and biodiversity 
loss to the threats posed by intensive animal agriculture as 
a driver of zoonotic disease, a crucial factor in preventing 
future pandemics.35
What these structural dynamics suggest is a need to re- ex-
amine how scalar differences between domains of action 
(eg, local/global) and degrees of concern (eg, the category 
of ‘neglected disease’) are produced and re- produced by 
the institutions of global health governance, and what alter-
native configurations might better address our contempo-
rary world. In this context, the ongoing COVID-19 crisis 
is producing new assemblages of expertise and modes 
of intervention. The uneven impact of the coronavirus 
pandemic has been a reminder of the difference between 
contexts where strong public health systems exist (eg, New 
Zealand, Germany, Vietnam) and those where public health 
has been eroded by austerity and neoliberal approaches to 
healthcare (eg, UK, USA, Brazil). While the pandemic has 
given the lie to any self- evident divide between North and 
South, it has also reignited calls to reckon with the colonial 
and exclusionary legacies that are constitutive of the global 
health enterprise.36
THE NEW SYNDEMICS
Global health institutions, norms, policy and practices have 
historically been configured by a prioritisation of the ‘big 
three’ (malaria, HIV and tuberculosis (TB)). Since the 
outbreak of the COVID-19 pandemic, some have decried 
the ‘COVIDisation’ of research,37 and of global health more 
generally, prompting concern from scholars and prac-
titioners for what is becoming a series of knock- on crises 
for maternal and child health, HIV, malaria, TB, cancer, 
fertility treatment, elective orthopaedics, among others. In 
its 2020 Goalkeepers Report, the Gates Foundation expressed 
concern that its focus on the ‘residual pandemics’ that still 
cause significant mortality and morbidity in low/middle- 
income countries (LMICs) was facing an existential threat 
from COVID-19. Such concern ironically recapitulates 
earlier critiques of global health for the way in which it 
‘siloed’ health programming while displacing attention to 
the structural determinants of health.4 In addition to the 
enduring health crises that have animated global health, 
COVID-19 has produced new syndemics and categories of 
vulnerability, particularly around malnutrition (including 
hunger and obesity), even while these map onto long- 
existing structures of inequality.
COVID-19 has rendered visible health categories that 
had previously only occupied those in public health or 
medicine. In the process, these categories have also been 
mainstreamed as part of the pandemic’s explanatory 
lexicon. Politicians and the public now equally talk of 
‘pre- existing’ conditions—a flexible shorthand for a variety 
of chronic, non- communicable diseases (NCDs)—that 
are used to mark out and explain risk and vulnerability 
to ‘serious illness’ should an individual contract COVID-
19.38 The category of NCDs has long stood in contrast to 
those diseases spread by pathogens, rather than patho-
genic conditions. Yet we have been repeatedly warned that 
those same pathogenic living conditions—urbanisation, 
inequality, globalisation, intensive agriculture and envi-
ronmental degradation—that were understood to drive 
the risk of NCDs are also those that enable the emergence 
of novel infectious diseases.39 40 With NCDs modulating 
the risk of morbidity and mortality for COVID-19 and the 
disease itself creating long- term, chronic sequelae, the 
distinction between categories of communicable and non- 
communicable is increasingly porous. As some have thus 
noted, COVID-19 is not simply a viral infection, but rather 
a complex syndemic with clinical and structural vulnerabil-
ities entrenched by existing poor health, employment and 
precarity, deprivation and inequalities.38 41 42 As the catego-
ries, crises and scaffolding of the global health enterprise 
transform, new questions are emerging of how to recon-
ceptualise the architecture of global health.
Before the advent of HIV/AIDS, Stephen Morse argued 
that, ‘it had become commonplace to suggest that infec-
tious diseases were about to become a thing of the past and 
that chronic, non- infectious diseases should be our major 
priorities’.39 The notion of the ‘epidemiological transition’ 
has not borne out for developed or developing contexts,43 44 
as the COVID-19 crisis makes plain. The ‘smug sense of 
immunity from infectious diseases that characterised health 
professionals in North America and Europe’45 has given 
way to a new emerging infectious disease paradigm, char-
acterised by preparedness and simulation.46 COVID-19 has 
revealed the lack of pandemic preparedness and compla-
cency about emergent infectious disease in Europe and 
the USA, and in many cases the chronic underfunding of 
public systems that were previously robust. It has also called 
into question the ways in which pandemic preparedness is 
measured and understood in high- income settings.30 47
Despite Morse’s fear that the chronic has been prioritised 
over the infectious, funding for NCDs within the complex 
ecosystem of global health has consistently remained below 
2% of total disbursements.48 While national health policies 
in the global North may have side- lined the ever- present 
threat of epidemic possibility, the spectre of infectious 
disease threats including in the form of drug- resistant infec-
tions has loomed in recent years.49 The global nature of 
these threats has been articulated in the rhetoric of health 
security, recognising the danger emergent from global 
health ‘hotspots’, particularly in sub- Saharan Africa. Here, 
international donor money and priorities have largely 
dictated domestic health agendas, regardless of the partic-
ularity of biomedical need.50 Indeed, in almost all coun-
tries, rising rates of chronic disease coexist with actual and 
potential infectious disease threat. The problem then is 
not really whether infectious diseases were deprioritised or 
not, but rather that the unwillingness to prioritise chronic 
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diseases within global health has consistently undermined 
efforts to address the broad political, economic, social and 
environmental determinants of health conceptualised in the 
broadest possible sense. Despite 40 years of appeals to pay 
attention to ‘structural determinants’, the social determi-
nants of health remain a sanitised framework that risks 
overlooking health justice as a key component of achieving 
health for all.51
Perhaps most importantly, the pandemic has laid bare 
the global lack of adequate attention to the upstream 
drivers of health within the global health enterprise. 
Global health has largely failed either to sustain much 
interest in, or to have any concrete impact on, the condi-
tions that create vulnerability to disease exposure, the 
likelihood of serious illness or the possibility of recovery.
A key example is the efforts to link human and animal 
health within a global governance regime of one health 
or planetary health over the last decade. It has proven 
difficult to join up zoonotic disease, biodiversity loss, and 
climate change into either a meaningful global polit-
ical order or workable global health endeavour.52 The 
COVID-19 pandemic brings these interdependencies 
sharply into focus: while the specific origins of COVID-19 
remain uncertain, it has become clear that the pandemic 
is a consequence of the intensive and globalised nature of 
the contemporary food system.53 The virus emerged in an 
agricultural setting and spread through global networks of 
trade, tourism and commerce. COVID-19 has generated 
an amplified awareness of the risks of zoonotic disease and 
of the latent potential of new epidemics due to land use 
change and industrial agriculture. It also reveals a lack of 
appreciation of evolutionary ecology and host–pathogen 
coevolution. Rather than militarised vocabularies of an 
‘arms race’ against microbes which sees disease eradication 
as the goal, a more dynamic understanding would frame 
health as adaptation rather than absolutist concepts of 
health with humans positioned as sovereign agents.
THE RETURN TO LAW AS USUAL
Global health as an organising logic has depended on 
particular arrangements of institutions, policies, norms and 
instruments. The development of international law and 
global health governance has been a key factor in the func-
tioning of these systems. Even before the COVID-19 crisis, it 
was difficult to gain consensus on global health law.54 Many 
new institutions and funders were unilaterally engaged in 
making ‘soft’ laws that often focused on single issues at the 
expense of collective decision- making.55 The legal land-
scape for infectious diseases was fragmented and crowded 
with multiple competing actors and regimes that covered 
many areas such as health security, border control, surveil-
lance, trade and intellectual property.56 This fragmentation 
has made it difficult to create cohesive legal regimes that 
recognise the impacts of planetary degradation on health 
outcomes. For example, attempts to link global health law 
to planetary health through instruments such as the Paris 
Agreement have established weak obligations on states and 
thus have not translated into cohesive action.
The COVID-19 pandemic has however forced a renewed 
recognition of the centrality of law in declaring and 
managing health crises. States have used law strategically 
to gain better health outcomes for citizens and to push 
nationalist agendas.57 Many countries have passed emer-
gency regulations with little or no scrutiny.58 At the inter-
national level, both states and international actors have 
expressed heightened interest in the International Health 
Regulations (IHR) 2005, which are the sole binding global 
legal instrument dedicated to the prevention and control 
of the international spread of infectious disease. While 
these rules have had some effect, they have also been stra-
tegic tools with performative value, allowing some states 
to ignore obligations under the IHR while pressuring the 
WHO to act on other issues. For instance, although many 
states created emergency laws in order to close borders, on 
the basis of Article 43 of the IHR, these border closures 
were far from universal. The WHO has also been accused of 
declaring the COVID-19 crisis a Public Health Emergency 
of International Concern—its highest alert level—too late, 
yet at the same time, the majority of states have ignored 
the WHO’s advice on a wide range of issues from border 
closures, contact tracing, vaccine nationalism to stockpiling 
products at the expense of developing countries.59 60
The COVID-19 pandemic has also given the lie to the 
notion that good global health governance could ensure 
just and equitable distribution by means of law alone. For 
example, the distribution of vaccines is predicated on 
countries’ abilities to purchase supplies, leaving developing 
countries at the back of the queue. Attempts by developing 
countries to relax World Trade Organization rules so that 
LMICs could create their own vaccines have faced resis-
tance from HICs and Big Pharma. In the face of a truly 
global crisis, it is clear that revolutionising the law to create 
greater access to essential medicines is extremely difficult. 
Instead, the law frames the crisis as an exception and rein-
states existing inequities in the political economy of access 
to health.
CONCLUSION
The COVID-19 pandemic has shone a harsh light on the 
fractures and limitations of the global health apparatus, 
forcing a generalised rethink of institutional arrangements 
and modes of action. Whatever governance regimes for 
health and climate emerge from the current crises, we 
will need a new, and better, concept of ‘the global’, even 
as states reinvent the social compacts that have histori-
cally shaped claims to rights and protections in particular 
national contexts. As consensus emerges on the triple 
threats of global heating, zoonoses and worsening, racial-
ised inequalities, new models of cooperation, equitable 
partnership and accountability that avoid exploitative logics 
of economic growth will be needed.61 62 There is increased 
advocacy for a just model of health that recognises the 
shared suffering of diverse human and non- human actors, 
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while acknowledging the claims for a healthy future made 
by generations of diverse life forms.63 The concept of plan-
etary justice is gaining traction across various domains and 
could prove a vital framework for a new, reimagined global 
health agenda.64–66 Such an agenda might be premised 
on solidarities that reach across national, class, spatial and 
species divisions, acknowledge historical debts and affirm 
mutual interdependencies.67–69 As WHO Director- General 
Tedros Ghebreyesus has said, “None of us are safe until all 
of us are safe.”
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